ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 617

$499K Total Retail Price of All Prescriptions

Rank: 100 out of 617

366 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 366 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 471 226 S3 1 8
LEVOTHYROXINE SODIUM 456 408 2 1
OMEPRAZOLE 417 374 3 3
AMLODIPINE BESYLATE 389 389 4 6
SIMVASTATIN 380 357 5 2
LISINOPRIL 360 351 6 5
METOPROLOL TARTRATE 306 302 7 11
FUROSEMIDE 280 238 8 4
GABAPENTIN 263 198 9 16
POTASSIUM CHLORIDE 262 243 10 10
WARFARIN SODIUM 259 241 11 7
HYDROCHLOROTHIAZIDE 212 212 12 13
ATENOLOL 188 187 13 17
DONEPEZIL HCL 163 163 14 30
CITALOPRAM HBR 147 124 15 18
METOPROLOL SUCCINATE 141 139 16 12
METFORMIN HCL 138 126 17 9
ATORVASTATIN CALCIUM 135 130 18 14
NAMENDA 135 135 18 35
SERTRALINE HCL 127 113 20 20
PREDNISONE 124 121 21 31
SPIRONOLACTONE 115 92 22 42
FENTANYL 109 40 S2 23 45
FAMOTIDINE 106 92 24 54
QUETIAPINE FUMARATE 98 98 25 78
TRAMADOL HCL 84 42 26 15
ESCITALOPRAM OXALATE 81 51 27 65
MIRTAZAPINE 80 79 28 50
LOSARTAN POTASSIUM 79 65 29 22
PRAVASTATIN SODIUM 79 79 29 21
ALENDRONATE SODIUM 76 76 31 25
CARVEDILOL 71 71 32 19
TRAZODONE HCL 69 57 33 51
TRIAMCINOLONE ACETONIDE 68 68 34 102
ZOLPIDEM TARTRATE 68 33 34 23
ISOSORBIDE MONONITRATE ER 67 67 36 52
BENAZEPRIL HCL 63 63 37 44
CRESTOR 62 62 38 28
ADVAIR DISKUS 62 51 38 38
NEXIUM 61 56 40 43
TAMSULOSIN HCL 59 50 41 26
CYMBALTA 57 32 42 49
CEPHALEXIN 53 49 43 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 49 44 29
SEROQUEL 51 51 45 218
PANTOPRAZOLE SODIUM 50 32 46 37
OXYCODONE HCL 50 0 S2 46 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.